Thyroid Pharmacology Flashcards
Drugs leading to Primary hypothyroidism
lithium, amiodarone* cholestyramine, phenytoin, carbamazepine
Treatment of Hypothyroidism
Replacement therapy: Levothyroxine (T4) children get highest dose, seniors get lowest dose.
Tx of hypothyroidism resolves Sx when?
Resolution of symptoms begins within 2-3 weeks
Requires 6-8 weeks of maintenance dose to reach steady-state plasma levels
Contraindication of hypo Tx
heart disease (use caution)
Hypothyroidism Treatment - Pregnancy considerations
Usually requires increase in dose due to:
- Increased levels of TBG (via estrogen) decreases free T4-T3 - no intact gland to increase production
- Increased placental metabolism of T4-T3
Myxedema coma: derangement and Tx
Acute medical emergency (low Na+, low glucose, hypothermia, shock, death)
- Large doses of T4 required: IV loading dose followed by daily IV dosing
- Hydrocortisone to prevent adrenal crisis as T4 may increase its metabolism
Levothyroxine pharmacokinetics
empty stomach with water, 30-60 min before breakfast or 4 hours after last meal in evening
Drugs that can impair absorption of levothyroxine include:
- Metal ions
- bile acid sequestrants,
- Avoid interaction by spacing levothyroxine dose 2 hrs before or 4-6 hrs after interacting drug
T of F: Changes in TBG levels or binding affinity will affect TOTAL serum levels
True, - NOT FREE
Drugs increasing thyroid hormone binding
Estrogens / SERMs
Drugs decreasing thyroid hormone binding
Anticonvulsants (phenytoin-carbamazepine)
Drugs that inhibit thyroid hormone activation
Glucocorticoids
Beta-blocke
Amiodarone
Propylthiouracil (higher doses)
Thyroid hormone Metabolic clearance rates
- Increased in hyperthyroidism and CYP450 induction - decreased by hypothyroidism
- Half-life of T4 = 7 days & Half-life of T3 = 1 day
- Degree of protein binding major factor for difference
- Long t1/2 T4: once-daily dose - Cp fluctuation 10%
Advantages of levothyroxine
- Stability, content uniformity, lack of allergenic protein (vs Thyroid USP)
- Low cost
- Once-daily dosing – minimal fluctuation
- Can be given orally or IV
Liothyronine
- synthetic T3
- Well absorbed, rapid action, but shorter duration of effect that permits quicker dosage adjustments (at 1-2 weeks intervals)
Liothyronine contraindications
- NOT recommended for routine replacement due to short t1/2 (greater Cp fluctuations between doses), high cost
- Should be avoided in patients with cardiac disease (increased T3 activity greater risk of cardiotoxicity)
- May increase risk of osteoporosis
Liotrix
4: 1 mixture of T4 and T3
- No advantage since T4 conversion to T3 in periphery results in near normal ratio
- More expensive
- Rarely required, not recommended
- May increase incidence of low TSH concentrations and increase markers of bone turnover
Thyroid USP
- Dessicated porcine thyroid extract containing T3 and T4
- Absorption characteristics and half-lives of T4 and T3 are same as in non-combination products
Thyroid USP disadvantages
Variable T4/T3 ratio and content unexpected toxicities
Protein antigenicity
Product instability
Less desirable than levothyroxine - current recommendation is use in hypothyroidism should be avoided
Thyroid hormone replacement ARS and DDI
-Toxicity: directly related to plasma hormone level equivalent to signs and symptoms of hyperthyroidism
Drug interaction with thyroid hormones
-Increased adrenergic effect of sympathomimetics: epi or decongestants (pseudoephedrine - phenylephrine)
Tx of Graves
Medications
-Antithyroid drugs (methimazole, propylthiouracil)- Inhibit synthesis of thyroid hormone
-Beta blockers- Reduce systemic hyperadrenergic symptoms and effects (primarily tremor, palpitations, etc.)
Radioactive Iodine (131I)
Surgery
Thionamides:
Methimazole - PTU (propylthiouracil)
Thionamides use in graves`
Methimazole until remission (1-15 yrs)
β-blocker for symptom relief until hyperthyroidism resolved
-Propranolol has advantage of blocking T4->T3 conversion
-Metoprolol-atenolol are beta1 selective, longer t1/2
Thionamides MOA
Inhibit thyroid peroxidase: prevent T4 / T3 synthesis
use of thionamides in hyperthyroidism
Only for thyrotoxicosis from excess production (Graves disease - high RAI) NOT excess release (low RAI)